Nuclear Medicine & Radiation Therapy

José Canga Rodríguez

Publications

• Research Article
  Biochroma - A New and Patented Technology for Processing Radioactive Wastewater from Nuclear Medicine Therapy Facilities in Hospitals and Clinics
  Author(s): José Canga RodríguezJosé Canga Rodríguez
  
  While undergoing nuclear medicine therapy using 131I radioisotope at a hospital, patients generate wastewater with a considerable amount of radioactivity. Thus, contamination can reach levels of as much as 90% of the radioactive dose administered to the patient, depending on the type of therapy the patient underwent [1,2]. Given its radioactive half life of 8.02070 days, there is a significant risk of 131I radioisotope accumulation after its discharge into the sewer network (through sanitary wastewater) and into the environment. Therefore, it is advisable to collect this effluent in a separate system for its treatment prior to final discharge to the municipal sewer [3-8]. In spite of the clear scientific evidence of the severe contamination of this specific type of wastewater, a harmonised legal framework has still not been devised for all member states of the European Union. A surv.. Read More»
  DOI: 10.4172/2155-9619.1000117

  Abstract PDF